Abstract:Abstract Background Pharmacological modulation of cell fate decisions and developmental gene regulatory networks holds promise for the treatment of heart failure. Compounds that target tissue-specific transcription factors could overcome non-specific effects of small molecules and lead to the regeneration of heart muscle following myocardial infarction. Due to cellular heterogeneity in the heart, the activation of gene programs representing specific atrial and ventricular cardiomyocyte subtypes would be highly desirable. Chemical compounds that modulate atrial and ventricular cell fate could be used to improve subtype-specific differentiation of endogenous or exogenously delivered progenitor cells in order to promote cardiac regeneration. Methods Transcription factor GATA4-targeted compounds that have previously shown in vivo efficacy in cardiac injury models were tested for stage-specific activation of atrial and ventricular reporter genes in differentiating pluripotent stem cells using a dual reporter assay. Chemically induced gene expression changes were characterized by qRT-PCR, global run-on sequencing (GRO-seq) and immunoblotting, and the network of cooperative proteins of GATA4 and NKX2-5 were further explored by the examination of the GATA4 and NKX2-5 interactome by BioID. Reporter gene assays were conducted to examine combinatorial effects of GATA-targeted compounds and bromodomain and extraterminal domain (BET) inhibition on chamber-specific gene expression. Results GATA4-targeted compounds 3i-1000 and 3i-1103 were identified as differential modulators of atrial and ventricular gene expression. More detailed structure-function analysis revealed a distinct subclass of GATA4/NKX2-5 inhibitory compounds with an acetyl lysine-like domain that contributed to ventricular cells (%Myl2-eGFP+). Additionally, BioID analysis indicated broad interaction between GATA4 and BET family of proteins, such as BRD4. This indicated the involvement of epigenetic modulators in the regulation of GATA-dependent transcription. In this line, reporter gene assays with combinatorial treatment of 3i-1000 and the BET bromodomain inhibitor (+)-JQ1 demonstrated the cooperative role of GATA4 and BRD4 in the modulation of chamber-specific cardiac gene expression. Conclusions Collectively, these results indicate the potential for therapeutic alteration of cell fate decisions and pathological gene regulatory networks by GATA4-targeted compounds modulating chamber-specific transcriptional programs in multipotent cardiac progenitor cells and cardiomyocytes. The compound scaffolds described within this study could be used to develop regenerative strategies for myocardial regeneration.

Abstract 18798: Gata4 and Gata6 Are Necessary for Neonatal but Not Adult Cardiac Function Under Normal Physiological Conditions

Novel Roles of GATA4/6 in the Postnatal Heart Identified Through Temporally Controlled, Cardiomyocyte-Specific Gene Inactivation by Adeno-Associated Virus Delivery of Cre Recombinase

GATA4 is a Dosage-Sensitive Regulator of Cardiac Morphogenesis.

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

Gata 4 is Required for Maintenance of Postnatal Cardiac Function and Protection from Pressure Overload-Induced Heart Failure

Morphogenesis of the Right Ventricle Requires Myocardial Expression of Gata4.

Abstract 17290: Tead1 is Required for Cardiomyocyte Proliferation

Abstract 19996: Cardiac Mesenchymal Stem Cells with High Endogenous Gata4 Promoter Activity Have Superior Capacity to Elicit Cardiac Repair

From embryogenesis to adulthood: Critical role for GATA factors in heart development and function

Conditional ablation of nonmuscle myosin II-B delineates heart defects in adult mice.

Gata6 functions in zebrafish endoderm to regulate late differentiating arterial pole cardiogenesis

Abstract 1057: MRTF-A and MRTF-B Mediate Redundant Functions Required for Cardiac Development

Induction of Senescence by Loss of Gata4 in Cardiac Fibroblasts

Gata And Nkx Factors Synergistically Regulate Tissue-Specific Gene Expression And Development In Vivo

[Role of GATA-4 in Cardiac Development and Remodeling].

GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesis

Abstract 20514: Cardiac-Specific Overexpression of Histone Deacetylase 4 Promotes Cardiac Dysfunction and Enhances Cardiac Remodeling

Abstract 658: RNF20/40 Regulates Cardiomyocyte Maturation

Nkx2-5 Represses Gata1 Gene Expression and Modulates the Cellular Fate of Cardiac Progenitors During Embryogenesis

Abstract 13368: Acetylation of VGLL4 Tdu Domain Modulates Its Activity to Regulate Postnatal Cardiac Growth (best of Basic Science Abstract)

GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line